GC Cell Corporation

₩9,940As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:144510Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (8.25%)
Div yield —
ROE (79.19%)
Biotechnology
Beta (5Y) 0.68
PE TTM —
TSR TTM (56.69%)
Mkt cap ₩149.4B
ROIC (3.74%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩10,481
5.44%
(45.82%)
Hold 10|10|8|10|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
134.85
129.10
129.56
140.41
9.61%
(3.83%)
(1.63%)
2.80%
Revenue₩B
18.33
18.70
18.93
19.89
7.54%
5.63%
5.81%
9.20%
Peers (US$110.1M)
Cap (US$)
PE
120.5M
30.07x
117.6M
—
110.0M
—
Capital
TTM
5Y
10Y
Leveragex
0.903
(0.055)
(0.053)
EBIT/Intx
1.235
0.213
0.229
Own earn%
(18.81)
(95.46)
(91.82)
Sh yield%
24.97
42.20
40.83
Owners
Insiders/Inst%
13.56
36.65
Short interest%
5.55
SBC / revenue%
5.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
15–19
$1 testx
−0.1
Incr. ROIC%
9